triamterene has been researched along with pyrimethamine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Gibson, CL; Huggan, JK; Hunter, WN; Iulek, J; Lee, JH; Martini, VP; Smith, TK; Suckling, CJ; Tulloch, LB | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Heilmann, E | 1 |
| Heischkeil, R | 1 |
| Baugh, CM; Gaut, ZN; Solomon, HM | 1 |
| Scott, JM; Weir, DG | 1 |
| Anguita, T | 1 |
3 review(s) available for triamterene and pyrimethamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Drug-induced megaloblastic anemia].
Topics: Alcoholism; Anemia, Macrocytic; Anemia, Megaloblastic; Anti-Bacterial Agents; Anticonvulsants; Antimetabolites, Antineoplastic; Contraceptives, Oral; Drug-Related Side Effects and Adverse Reactions; Folic Acid Antagonists; Humans; Malabsorption Syndromes; Pyrimethamine; Triamterene; Trimethoprim; Vitamin B 12 | 1979 |
Drug-induced megaloblastic change.
Topics: Cyclophosphamide; Cytarabine; DNA; Erythrocytes, Abnormal; Floxuridine; Fluorouracil; Folic Acid Antagonists; Humans; Hydroxyurea; Megaloblasts; Methotrexate; Phenytoin; Pyrimethamine; Ribonucleotides; Thymidine Monophosphate; Thymidylate Synthase; Triamterene; Trimethoprim | 1980 |
6 other study(ies) available for triamterene and pyrimethamine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases.
Topics: Catalytic Domain; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Leishmania major; Leishmaniasis; Models, Molecular; Molecular Structure; Oxidoreductases; Parasitic Sensitivity Tests; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Trypanosoma brucei brucei; Trypanosomiasis, African | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
[Antimetabolites of folic acid metabolism with chemotherapeutic activity against rodent malaria (Plasmodium vinckei)].
Topics: Aminopterin; Animals; Cycloheximide; Female; Folic Acid; Folic Acid Antagonists; Hydantoins; Malaria; Male; Methotrexate; Mice; Mice, Inbred Strains; Phenobarbital; Phenytoin; Plasmodium; Primidone; Pyrimethamine; Thalidomide; Triamterene | 1973 |
Accumulation of (3',5'-3H2)folic acid by human blood platelets. Effect of dihydrofolic acid reductase inhibitors.
Topics: Aminopterin; Biological Transport, Active; Blood Platelets; Diffusion; Folic Acid; Folic Acid Antagonists; Humans; Kinetics; Methotrexate; Pyrimethamine; Triamterene; Tritium | 1970 |
[Bone marrow megaloblastosis associated with the use of pyrimethamine, triamterene and trimethoprim-sulfamethoxazole].
Topics: Adult; Aged; Anemia, Macrocytic; Anemia, Megaloblastic; Bone Marrow; Drug Combinations; Female; Folic Acid Antagonists; Humans; Male; Megaloblasts; Middle Aged; Pyrimethamine; Sulfamethoxazole; Triamterene; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1982 |